Annual Drug Patent Expirations for BALVERSA
Balversa is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier. There are six patents protecting this drug.
This drug has one hundred and sixty-eight patent family members in forty-three countries.
The generic ingredient in BALVERSA is erdafitinib. One supplier is listed for this compound. Additional details are available on the erdafitinib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
